Can a daily pill bring back hair in severe alopecia?
NCT ID NCT07749716
First seen Aug 06, 2026 · Last updated Aug 07, 2026 · Updated 1 time
Summary
This trial is testing an experimental oral medication, VC005, in adults with severe alopecia areata—an autoimmune condition that causes patchy or complete hair loss. Participants will take either VC005 or a placebo daily for 24 weeks. The main goal is to see if the drug can reduce hair loss severity, measured by a standard scoring tool, and to assess its safety.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- VC005 tablets
- What this could lead to
- If successful, VC005 could offer a new oral treatment option for people with severe alopecia areata, potentially restoring significant hair growth.
- What could go wrong
- This is an early-phase trial with a modest number of participants, so results may not hold up in larger studies. The drug may also have side effects or fail to outperform a placebo.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALOPECIA AREATA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Peking University People's Hospital, Beijing, Beijng
Beijing, Beijing Municipality, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new pill help teens regrow hair lost to alopecia?
- Can allergy and glaucoma drugs regrow hair when delivered by microneedling?
- Can Real-World data unlock better skin disease care?
- Can a daily pill regrow hair in alopecia areata? a trial seeks answers
- Blood test may reveal hidden clues to hair loss severity
- Hair loss and hidden struggles: study probes depression in alopecia areata